Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy

Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy

BACKGROUND: 5-HT3-receptor antagonists are one of the mainstays of antiemetic treatment, and they are administered either i.v. or orally. Nevertheless, sometimes neither administration route is feasible, such as in patients unable to admit oral intake managed in an outpatient setting. Our objecti...

Descrizione completa

Dettagli Bibliografici
Autori principali: Gurpide, A. (Alfonso), Sadaba, B. (Belén), Martin-Algarra, S. (Salvador), Azanza, J.R. (José Ramón), Lopez-Picazo, J.M. (José M.), Campanero, M.A. (Miguel Angel), Cabello, J.P. (J.P.), Gil-Aldea, I. (I.), Cruz, S. (S.) de la, Fernandez-Gallego, V. (V.), Reyna, C. (Carmen), Olier, C. (Clara), Blanco-Prieto, M.J. (María José), Ceballos-Viro, J. (Jaime), Garcia-Foncillas, J. (Jesús), Perez-Gracia, J.L. (Jose Luis)
Natura: info:eu-repo/semantics/article
Lingua:eng
Pubblicazione: AlphaMed Press 2011
Soggetti:
Emesis
Granisetron
Pharmacokinetics
Subcutaneous
Accesso online:https://hdl.handle.net/10171/19115

Accesso online

https://hdl.handle.net/10171/19115

Documenti analoghi